Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (41-50 of 1,725) with videos related to

Pageof 173
Sort By:
Methods in Enzymology|November 13, 2003
Liposomes in the study of membrane fusion in neutrophilsJames E Smolen
Annals of the Rheumatic Diseases|March 4, 2021
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by CharlesJosef S Smolen
Annals of the Rheumatic Diseases|May 18, 2005
In the middle of the decadeJ S Smolen
Arthritis Research & Therapy|August 11, 2006
Expanding the frontiers of therapyJosef S Smolen
The Journal of Rheumatology. Supplement|July 6, 2007
What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trialsJosef S Smolen
Annals of the Rheumatic Diseases|December 26, 2025
Greetings from the editor-2026Josef S Smolen
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target: rationale and strategiesJosef S Smolen
Alcohol (Fayetteville, N.Y.)|January 1, 1990
Pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate concentrations in blood and tissues of mice fed ethanol-containing liquid dietsD Leibman, D Furth-Walker, T N Smolen, et al.
Current Opinion in Rheumatology|March 31, 2016
Treat-to-target as an approach in inflammatory arthritisJosef S Smolen
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1976
Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and proceduresV F Smolen
Pageof 173

Showing results (41-50 of 1,725) with videos related to

Sort By:
Pageof 173
Methods in Enzymology|November 13, 2003
Liposomes in the study of membrane fusion in neutrophilsJames E Smolen
Annals of the Rheumatic Diseases|March 4, 2021
Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by CharlesJosef S Smolen
Annals of the Rheumatic Diseases|May 18, 2005
In the middle of the decadeJ S Smolen
Arthritis Research & Therapy|August 11, 2006
Expanding the frontiers of therapyJosef S Smolen
The Journal of Rheumatology. Supplement|July 6, 2007
What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trialsJosef S Smolen
Annals of the Rheumatic Diseases|December 26, 2025
Greetings from the editor-2026Josef S Smolen
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target: rationale and strategiesJosef S Smolen
Alcohol (Fayetteville, N.Y.)|January 1, 1990
Pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate concentrations in blood and tissues of mice fed ethanol-containing liquid dietsD Leibman, D Furth-Walker, T N Smolen, et al.
Current Opinion in Rheumatology|March 31, 2016
Treat-to-target as an approach in inflammatory arthritisJosef S Smolen
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1976
Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and proceduresV F Smolen
Pageof 173